His current research interest is the clinical, pathophysiology, and pharmacology of primary headaches, particularly migraine. He has authored 110 peer reviewed articles in the fields of neuropharmacology, neurogenetics and clinical neurology and has an H-index of 22. He is an ad hoc reviewer for several journals in the field including Cephalalgia, Headache, Journal of Headache and Pain, European Journal of Neurology, Journal of Neurology, Neurosurgery and Psychiatry, and Neurological Sciences. He has led as principal investigator 43 phase IIb, III and IV pharmacological clinical trials on headaches, pain, dementia, epilepsy, multiple sclerosis, and movement disorders. He is a scientific consultant for the TV program Geo on Rai3.
Prof. Piero Barbanti is in charge of the IRCCS San Raffaele Headache and Pain Diagnosis and Therapy Center at which, in a short time, the patient can undergo a general medical examination, a neurological examination, any diagnostic tests that the specialist deems appropriate, and a careful and thorough interview that will allow reconstructing the specific characteristics of a certain type of headache. Therapies for headaches must take into account each individual patient’s medical and psychological history, and thus must be highly individualized.
Dedicated to adults and children, the Headache and Pain Diagnosis and Therapy Center represents one of the first nationwide initiatives in rehabilitation aimed at functional pain rehabilitation. Addresses the treatment of patients, both adults and children, with migraine, chronic headaches and chronic algias.
According to the World Health Organization, migraine is among the top 12 most disabling diseases of humankind. Twelve percent of adults worldwide suffer from it. In Italy, 6 million people struggle with headaches. Three-quarters are women. The severity of migraine attacks can vary greatly but is never mild; typical symptoms include sensitivity to light, noise, and motion and nausea and vomiting in addition to the headache.